eCardiacRehab - a Hybrid Patient-Centered eHealth Programme

NCT07590635 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2026-05-15

No results posted yet for this study

Summary

The overall aim of eCardiacRehab trial is to meet rehabilitation needs of patients with coronary artery disease (CAD) regardless of their access to traditional place-based rehabilitation by developing and evaluating the efficacy and cost effectiveness of an interdisciplinary and comprehensive home-based hybrid programme. eCardiacRehab address patient- and system level challenges to increase access to cardiac rehabilitation (CR). We give particular attention to older patients, women, and those with comorbidities or mental health challenges. The vision of the hybrid home-based eCardiacRehab programme is to make CR available to all.

eCardiacRehab is a prospective, multicentre randomized open-label blinded end point evaluation (PROBE) trial. The primary endpoint is a hierarchical composite endpoint using a win-ratio framework combining cardiovascular (CV) death, unplanned contacts to the Emergency Department (ED) for observation or admission (\>24 hours) for CV disease, and quality of life. Inclusion criteria are adult Scandinavian speaking patients (≥ 18 years) who have a Norwegian national identification number, with CAD treated with Percutaneous Coronary Intervention (PCI), are living at home, and have internet available to them and providing signed informed consent. Exclusion criteria are patients with severe aortic stenosis, severe arrhythmias, expected lifetime less than one year as determined by study personnel, otherwise clinically unstable, not fully revascularized, awaits PCI or coronary artery bypass graft operation (CABG) or inability to comply with the study protocol due to any physical disability, somatic disease, cognitive impairment or mental health challenges as determined by study personnel.

Conditions

  • Comorbidities and Coexisting Conditions
  • Ethics
  • Continuity of Patient Care
  • Older Adults (65 Years and Older)
  • Cost-Benefit Analysis
  • Adherence, Medication
  • Secondary Prevention of Coronary Heart Disease
  • Health Literacy
  • eHealth Literacy
  • Mental Health
  • Cardiac Rehabilitation
  • Womens's Health
  • Coronary Artery Disease (CAD)

Interventions

OTHER

eCardiacRehab

12-week digital cardiac rehabilitation

Sponsors & Collaborators

  • The Research Council of Norway

    collaborator OTHER
  • Helse Vest

    collaborator OTHER
  • Helse Fonna

    collaborator OTHER
  • Helse Møre og Romsdal HF

    collaborator OTHER_GOV
  • Helse Vest IKT

    collaborator UNKNOWN
  • Western Norway University of Applied Sciences

    collaborator OTHER
  • Youwell

    collaborator UNKNOWN
  • University of Bergen

    collaborator OTHER
  • Østfold University College

    collaborator UNKNOWN
  • Norsk råd for digital etikk

    collaborator UNKNOWN
  • Helse Førde HF

    collaborator UNKNOWN
  • University of Amsterdam

    collaborator OTHER
  • Center for Research on Cardiac Disease in Women

    collaborator UNKNOWN
  • Nasjonal kompetansetjeneste Trening som medisin

    collaborator UNKNOWN
  • RELIS Vest

    collaborator UNKNOWN
  • Norwegian Centre for E-health Research

    collaborator UNKNOWN
  • Bergen Municipality

    collaborator UNKNOWN
  • Sunnfjord Municipality

    collaborator UNKNOWN
  • Sogndal Municipality

    collaborator UNKNOWN
  • Masfjorden Municipality

    collaborator UNKNOWN
  • The Norwegian Heart and Lung Patients Association (LHL)

    collaborator UNKNOWN
  • E-helse Vestland

    collaborator UNKNOWN
  • Yale University

    collaborator OTHER
  • University of Sydney

    collaborator OTHER
  • University of Cambridge

    collaborator OTHER
  • University of Regina

    collaborator OTHER
  • University of Copenhagen

    collaborator OTHER
  • Linkoeping University

    collaborator OTHER_GOV
  • Voss Sykehus

    collaborator UNKNOWN
  • Haukeland University Hospital

    lead OTHER

Principal Investigators

  • Tone M Norekvål, PhD · Haukeland University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-04
Primary Completion
2027-12-31
Completion
2037-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07590635 on ClinicalTrials.gov